Warady, Bradley A.
Ng, Eric
Bloss, Laura
Mo, May
Schaefer, Franz
Bacchetta, Justine
Funding for this research was provided by:
Amgen Inc
Article History
Received: 14 August 2019
Revised: 18 February 2020
Accepted: 21 February 2020
First Online: 4 May 2020
Compliance with ethical standards
:
: Bradley A. Warady has received consulting fees from Amgen, Inc. Eric Ng, Laura Bloss, and May Mo are employees of and own stock in Amgen Inc. Franz Schaefer has received personal fees from Amgen Inc. Justine Bacchetta has received research grants and consulting fees from Amgen, Inc.
: There is a plan to share data. This may include de-identified individual patient data for variables necessary to address the specific research question in an approved data-sharing request; also, related data dictionaries, study protocol, statistical analysis plan, informed consent form, and/or clinical study report. Data sharing requests relating to data in this manuscript will be considered after the publication date, and (1) this product and indication (or other new use) have been granted marketing authorization in both the USA and Europe, or (2) clinical development discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for these data. Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of reevaluating safety and efficacy issues already addressed in the product labelling. A committee of internal advisors reviews requests. If not approved, requests may be further arbitrated by a Data Sharing Independent Review Panel. Requests that pose a potential conflict of interest or an actual or potential competitive risk may be declined at Amgen’s sole discretion and without further arbitration. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the following: ExternalRef removed